January 1, 2025
An Imaging-related Clinical Trial Endpoint
Ellipsoid zone integrity is an OCT biomarker in dry age-related macular degeneration that the FDA now supports as an approvable clinical trial endpoint.
2024 American Academy of Ophthalmology Annual Meeting
Related Articles
October 25, 2024
Paul Hahn, MD, PhD, Discusses Physician Reimbursement at AAO
During Retina Subspecialty Day at AAO 2024, Paul Hahn, MD, PhD, discussed recent studies that examined the financial impact of step therapy and inflation on retinal physician reimbursement. The studies were performed by the Health Economics Committee of the American Society of Retina Specialists.
October 25, 2024
Gene Therapy Discussion With Drs. Kaiser and Do at AAO
Peter K. Kaiser, MD, and Diana V. Do, MD, discuss first-time results of a bilateral dosing study of subretinal ABBV-RGX-314 for wet AMD.
October 25, 2024
Observations on the Schepens Lecture
Yasha Modi, MD, discusses the 17th Charles L. Schepens Lecture given by legendary innovator and surgeon Dr. Steve Charles during Retina Subspecialty Day at AAO 2024.
October 25, 2024
Gildeuretinol Demonstrates Benefit in Low-luminance Visual Function
Data from the SAGA study, presented at AAO, showed patients with geographic atrophy demonstrated a trend toward functional benefit in BCVA at month 24.
October 25, 2024
Regeneron Leaders Recognized for Innovation at Eyecelerator 2024
Drs. Schleifer and Yancopoulos received the Eyecelerator Innovation Award and discussed the long and winding road to success.
October 19, 2024
Fellow Eye Dosing of Gene Therapy Found Safe, Effective
First-time results of a bilateral dosing study of subretinal ABBV-RGX-314 for nAMD were presented during Retinal Subspecialty Day at AAO.
October 19, 2024
Ocular Insert Shows Potential as MacTel Treatment
Pooled data from 3 clinical trials, presented during the AAO meeting in Chicago, indicates revakinagene taroretcel prevents deterioration of visual function.
October 19, 2024
Epiretinal Membrane Tips From Yasha Modi, MD, at AAO
Yasha Modi, MD, discusses the decision-making process for surgical treatment of epiretinal membrane during Saturday's Retina Subspecialty Day at the 2024 American Academy of Ophthalmology meeting in Chicago.
October 19, 2024
Eylea HD Data Discussion With Drs. Kaiser and Do at AAO
Peter K. Kaiser, MD, and Diana Do, MD, discuss 3-year data from the PHOTON trial for diabetic macular edema at the 2024 American Academy of Ophthalmology meeting.
October 18, 2024
Transformative Strategies in Ocular Oncology Presented at AAO 2024
Evolving approaches to treatment, and advancements in identifying and treating ocular melanomas, have greatly improved patient survival rates and quality of life.
October 18, 2024
Faricimab Effective in Underrepresented DME Patients
Data from the ELEVATUM trial, presented at AAO, indicates that Hispanic and Black patients with diabetic macular edema responded well to treatment with faricimab.
October 18, 2024
Pegcetacoplan an Effective Treatment for Subfoveal GA
Three-year data from the GALE open-label extension study, presented at AAO, demonstrated an anatomical and visual function benefit of continuous pegcetacoplan treatment for patients with subfoveal geographic atrophy.
October 18, 2024
Scleral Buckling: Let There Be Light
The chandelier scleral buckle procedure, using radial or segmental sponge explants, offers better visualization, reducing complications and improving outcomes.
October 18, 2024
An AAO Conversation With Steve Charles
The legendary surgeon and innovator delivered the 17th Charles Schepens Lecture during Retina Subspecialty Day on Friday morning. He spoke with Retinal Physician about this honor.
October 18, 2024
Data Presented at AAO Support Utility of Home OCT
Data from 2 pivotal trials showed that the Scanly Home OCT device offers accurate, reliable monitoring for nAMD patients between office visits.